Mesa Laboratories, Inc. (MLAB): History, Ownership, Mission, How It Works & Makes Money

Mesa Laboratories, Inc. (MLAB): History, Ownership, Mission, How It Works & Makes Money

US | Technology | Hardware, Equipment & Parts | NASDAQ

Mesa Laboratories, Inc. (MLAB) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Ever wondered about the company ensuring the safety and effectiveness of critical environments in healthcare and pharmaceuticals? That's Mesa Laboratories, Inc. (MLAB), a global leader in life science tools and critical quality control solutions. With a market capitalization of $597 million and a stock price of $109.86 as of April 10, 2025, Mesa Labs stands as a key player, but how exactly did they get here and what makes them tick? Keep reading to discover the history, ownership structure, mission, and revenue streams that define this impactful organization.

Mesa Laboratories, Inc. (MLAB) History

Mesa Laboratories, Inc. Founding Timeline

Year established

Mesa Laboratories, Inc. was established in 1982.

Original location

The company was originally located in Lakewood, Colorado.

Founding team members

The founding team members included:

  • Dr. John D. Gillis
  • Mr. Richard J. Schwab

Initial capital/funding

Information regarding the initial capital and funding for Mesa Laboratories' founding is not available in the provided search results.

Mesa Laboratories, Inc. Evolution Milestones

Year Key Event Significance
1982 Mesa Diagnostics, Inc. Founded Focused on clinical microbiology market, signaling early emphasis on healthcare-related solutions.
1985 Acquisition of Raven Biological Laboratories Expanded product offerings to include biological indicators, broadening capabilities in sterilization monitoring.
1989 Acquisition of Mesa Medical, Inc. Further diversified product lines, enhancing presence in the medical sector.
1993 Initial Public Offering (IPO) Became a publicly traded company, providing capital for growth and acquisitions.
2013 Acquisition of Amsco product line Expanded infection control segment.
2016 Acquisition of Biological Indicators, Inc. (BII) Enhanced presence in the biological indicators market, strengthening the company’s core offerings.
2018 Acquisition of Agena Bioscience, Inc. Expanded into the clinical genomics space, diversifying technology platforms.
2024 Revenue of $184.5 million reported Demonstrates continued growth and market presence in its key segments.

Mesa Laboratories, Inc. Transformative Moments

Mesa Laboratories has undergone several transformative moments that have significantly shaped its trajectory:

  • Strategic Acquisitions: Mesa Laboratories has a history of strategic acquisitions, allowing it to expand its product lines and market reach. Acquisitions like Raven Biological Laboratories and Biological Indicators, Inc. strengthened its position in sterilization monitoring and biological indicators.
  • Diversification into New Markets: The acquisition of Agena Bioscience in 2018 marked a significant move into clinical genomics, showcasing the company's ability to diversify and adapt to new opportunities.
  • Focus on Innovation and Technology: Mesa's growth is underpinned by its focus on developing and acquiring innovative technologies. This emphasis has enabled the company to maintain a competitive edge and meet the evolving needs of its customers.
  • Financial Performance and Market Position: With a reported revenue of $184.5 million in 2024, Mesa Laboratories has demonstrated consistent financial growth and a strong market presence.

To gain more insights into Mesa Laboratories, Inc.'s financial health, consider reading: Breaking Down Mesa Laboratories, Inc. (MLAB) Financial Health: Key Insights for Investors

Mesa Laboratories, Inc. (MLAB) Ownership Structure

Mesa Laboratories, Inc. exhibits a mixed ownership structure, featuring a combination of institutional, insider, and retail investors. Understanding this structure provides insights into the company's governance and strategic decision-making.

Mesa Laboratories, Inc.'s Current Status

Mesa Laboratories, Inc. is a publicly traded company, meaning its shares are available for purchase on a stock exchange. As a publicly traded entity, it is subject to regulatory oversight and reporting requirements, ensuring transparency for investors. For more in-depth insights into the ownership dynamics, you might find this resource helpful: Exploring Mesa Laboratories, Inc. (MLAB) Investor Profile: Who’s Buying and Why?

Mesa Laboratories, Inc.'s Ownership Breakdown

The following table summarizes the ownership breakdown of Mesa Laboratories, Inc., providing a snapshot of the key stakeholders and their respective ownership percentages as of the latest available data.

Shareholder Type Ownership, % Notes
Institutions 88.46% Reflects holdings by investment firms, mutual funds, and other institutional investors.
Insiders 1.48% Includes shares held by company executives and board members.
Retail 10.06% Represents individual investors who hold shares in the company.

Mesa Laboratories, Inc.'s Leadership

The leadership team at Mesa Laboratories, Inc. is responsible for setting the strategic direction of the company and overseeing its operations. Key members of the leadership team include:

  • Gary Owens: President and Chief Executive Officer
  • John D. Wiseman: Executive Vice President and Chief Financial Officer
  • Todd Uslander: President, Sterilization and Disinfection Control

Mesa Laboratories, Inc. (MLAB) Mission and Values

Mesa Laboratories, Inc. focuses on safeguarding the critical processes of its customers through innovative solutions and unwavering integrity. The company's values emphasize quality, customer satisfaction, and a commitment to making a difference in the industries it serves.

Mesa Laboratories, Inc. Core Purpose

Official mission statement

Mesa Labs doesn't have a singular, formally published mission statement readily available in the same way some companies do. However, through their actions and public statements, their mission can be understood as a commitment to:

  • Providing high-quality products and services in the biopharmaceutical, healthcare, and industrial sectors.
  • Ensuring accuracy and reliability in critical quality control processes.
  • Innovating and improving solutions for customers' evolving needs.
  • Maintaining integrity and compliance in all operations.

Vision statement

Similar to its mission statement, Mesa Labs doesn't have a specific, formally published vision statement. However, inferences about their vision can be drawn from their strategic goals and long-term objectives:

  • To be a trusted global leader in the provision of quality control and monitoring solutions.
  • To expand their technological capabilities and product offerings to meet emerging market demands.
  • To foster a culture of innovation, excellence, and customer-centricity within the organization.
  • To deliver sustainable growth and value to shareholders through operational efficiency and strategic investments.

Company slogan/tagline

Mesa Laboratories does not have a widely publicized official slogan or tagline. However, given their focus, a fitting tagline might emphasize precision, reliability, and trust in critical measurements.

For detailed insights into Mesa Laboratories, Inc.'s financial well-being, explore Breaking Down Mesa Laboratories, Inc. (MLAB) Financial Health: Key Insights for Investors.

Mesa Laboratories, Inc. (MLAB) How It Works

Mesa Laboratories, Inc. operates by developing, manufacturing, and marketing quality control and monitoring instruments and consumables. These are used in healthcare, pharmaceutical, medical device, and industrial applications to ensure product and service quality, patient safety, and regulatory compliance.

Mesa Laboratories, Inc.'s Product/Service Portfolio

Product/Service Target Market Key Features
Biological Indicators (BIs) Pharmaceutical, medical device, and healthcare industries Used for sterilization validation and monitoring, ensuring that sterilization processes are effective in eliminating harmful microorganisms. Mesa Labs offers a wide range of BIs, including spore strips, self-contained vials, and customized options to meet specific customer needs.
Data Loggers Pharmaceutical, medical device, food, and healthcare industries Measure and record critical parameters such as temperature, pressure, and humidity in various applications, including sterilization, pasteurization, and environmental monitoring. Mesa's data loggers are known for their accuracy, reliability, and ease of use, providing users with comprehensive data for process validation and quality control.
Calibration Services Various industries requiring precise measurement and monitoring Mesa Labs provides accredited calibration services for a wide range of instruments, including temperature, pressure, and flow devices. These services ensure that instruments are accurate and reliable, helping customers meet regulatory requirements and maintain product quality.
Sterilization Equipment Hospitals, clinics, and research facilities Designs and manufactures steam sterilizers, ethylene oxide sterilizers, and vaporized hydrogen peroxide sterilizers. These sterilizers are used to sterilize medical devices, surgical instruments, and laboratory equipment, ensuring patient safety and preventing the spread of infection.
Continuous Monitoring Systems Pharmaceutical, biotechnology, and healthcare facilities Provide real-time monitoring of critical environmental parameters such as temperature, humidity, and differential pressure. These systems help customers maintain controlled environments, ensure product quality, and comply with regulatory requirements.

Mesa Laboratories, Inc.'s Operational Framework

Mesa Laboratories, Inc. focuses on the following operational strategies:

  • Product Development: Mesa Labs invests in research and development to create innovative products and solutions that meet the evolving needs of its customers. This includes developing new biological indicators, data loggers, and monitoring systems that offer improved performance, accuracy, and reliability.
  • Manufacturing: The company operates state-of-the-art manufacturing facilities that adhere to strict quality control standards. This ensures that its products are of the highest quality and meet the stringent requirements of the industries it serves.
  • Sales and Marketing: Mesa Labs employs a direct sales force and a network of distributors to reach its target markets. The company's sales and marketing efforts are focused on educating customers about the benefits of its products and solutions and providing them with the support they need to succeed.
  • Customer Service: Mesa Labs is committed to providing excellent customer service. The company offers a variety of services, including technical support, training, and calibration services, to help customers get the most out of its products.
  • Acquisitions: Mesa Labs has a history of acquiring companies that complement its existing business. These acquisitions have allowed the company to expand its product portfolio, enter new markets, and strengthen its competitive position. For example, in fiscal year 2024, Mesa Labs completed two acquisitions for a total consideration of $12.4 million.

Mesa Laboratories, Inc.'s Strategic Advantages

Mesa Laboratories, Inc. maintains its competitive edge through several key strategies:

  • Focus on Quality: Mesa Labs is committed to providing high-quality products and services that meet the needs of its customers. This commitment to quality has helped the company build a strong reputation in the industries it serves.
  • Strong Brand Recognition: Mesa Labs has a well-recognized brand name in the quality control and monitoring market. This brand recognition helps the company attract new customers and retain existing ones.
  • Innovative Products: Mesa Labs invests in research and development to create innovative products that meet the evolving needs of its customers. This innovation helps the company stay ahead of the competition and maintain its market leadership position.
  • Recurring Revenue Model: A significant portion of Mesa Labs' revenue comes from the sale of consumable products and services, such as biological indicators and calibration services. This recurring revenue model provides the company with a stable and predictable stream of income. In fiscal year 2024, recurring revenue accounted for approximately 67% of the company's total revenue.
  • Regulatory Expertise: Mesa Labs has a deep understanding of the regulatory requirements that its customers face. This expertise helps the company develop products and services that meet these requirements and helps its customers comply with applicable regulations.

To gain more insights into the ownership and investor profile of Mesa Laboratories, Inc., check out: Exploring Mesa Laboratories, Inc. (MLAB) Investor Profile: Who’s Buying and Why?

Mesa Laboratories, Inc. (MLAB) How It Makes Money

Mesa Laboratories, Inc. primarily generates revenue by providing instruments and consumables utilized in quality control processes, along with offering sterilization services to various industries.

Mesa Laboratories, Inc. Revenue Breakdown

Mesa Laboratories, Inc. operates through two main segments:

  • Sterilization and Disinfection Control: This segment offers indicators, and related products that confirm the effectiveness of sterilization and disinfection processes.
  • Biopharmaceutical Development: Focuses on providing process development, testing, and manufacturing services for biopharmaceutical companies.
Revenue Stream % of Total Growth Trend
Sterilization and Disinfection Control Approx. 57% Increasing
Biopharmaceutical Development Approx. 43% Increasing

Mesa Laboratories, Inc. Business Economics

  • Pricing Strategy: The company employs a premium pricing strategy for its high-quality products and services, emphasizing reliability and accuracy, which are critical in regulated industries.
  • Economic Moats: Mesa Laboratories, Inc. benefits from strong economic moats due to stringent regulatory requirements and the critical nature of its products, leading to high customer retention.
  • Market Position: As a leader in sterilization and disinfection control, the company leverages its brand reputation and technological expertise to maintain a competitive edge.

Mesa Laboratories, Inc. Financial Performance

  • In fiscal year 2024, Mesa Laboratories, Inc. reported revenue of $192.8 million, which represents an increase of 16.9% compared to fiscal year 2023.
  • The Sterilization and Disinfection Control segment reported revenue of $110.6 million, an increase of 11.4% compared to the prior year.
  • The Biopharmaceutical Development segment reported revenue of $82.2 million, an increase of 24.7% compared to the prior year.
  • Gross profit for fiscal year 2024 was $94.1 million, or 48.8% of revenue, compared to $79.7 million, or 48.1% of revenue, for fiscal year 2023.

To gain more insights into the financial health of Mesa Laboratories, Inc., you can explore this resource: Breaking Down Mesa Laboratories, Inc. (MLAB) Financial Health: Key Insights for Investors

Mesa Laboratories, Inc. (MLAB) Market Position & Future Outlook

Mesa Laboratories is strategically positioned within the life science tools and sterilization services sectors, demonstrating a commitment to innovation and quality. The company's future outlook is shaped by its ability to capitalize on market opportunities while effectively managing potential risks.

Competitive Landscape

The competitive landscape for Mesa Laboratories includes a mix of specialized and diversified companies. Here's a snapshot:

Company Market Share, % Key Advantage
Mesa Laboratories, Inc. Around 5-10% (estimated) Niche expertise in sterilization and biodecontamination; strong brand reputation for quality.
STERIS Corporation Around 20-25% (estimated) Comprehensive sterilization solutions; large installed base and global presence.
Cantel Medical (now part of STERIS) Around 10-15% (estimated prior to acquisition) Specialized in infection prevention and control; strong presence in endoscopy.

Opportunities & Challenges

Mesa Laboratories faces a dynamic environment with various opportunities and risks that could influence its future performance:

Opportunities Risks
Expanding its product line in continuous monitoring solutions to address the growing demand for real-time data in biopharmaceutical manufacturing. Intense competition from larger players with broader product portfolios and greater financial resources.
Capitalizing on regulatory changes that mandate more rigorous sterilization and decontamination processes in healthcare and pharmaceutical industries. Potential disruptions in the supply chain, affecting the availability of critical components and materials.
Acquiring smaller, innovative companies to broaden its technology base and market reach, particularly in niche applications. Risk of product obsolescence due to rapid technological advancements in sterilization and monitoring technologies.

Industry Position

Mesa Laboratories holds a significant position within its niche markets, characterized by:

  • A reputation for high-quality products and reliable services.
  • A focus on specialized applications within the broader life sciences and healthcare sectors.
  • Strong customer relationships built on trust and technical expertise.

To gain more insights into the company's financial standing, explore Breaking Down Mesa Laboratories, Inc. (MLAB) Financial Health: Key Insights for Investors.

DCF model

Mesa Laboratories, Inc. (MLAB) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.